期刊
VIRUSES-BASEL
卷 6, 期 10, 页码 4095-4139出版社
MDPI
DOI: 10.3390/v6104095
关键词
HIV-1; antiviral therapy; drug resistance; evolution; lethal mutagenesis; resistance monitoring
类别
资金
- National Institutes of Health [R01 GM49551]
Current advancements in antiretroviral therapy (ART) have turned HIV-1 infection into a chronic and manageable disease. However, treatment is only effective until HIV-1 develops resistance against the administered drugs. The most recent antiretroviral drugs have become superior at delaying the evolution of acquired drug resistance. In this review, the viral fitness and its correlation to HIV-1 mutation rates and drug resistance are discussed while emphasizing the concept of lethal mutagenesis as an alternative therapy. The development of resistance to the different classes of approved drugs and the importance of monitoring antiretroviral drug resistance are also summarized briefly.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据